BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 32194774)

  • 1. Overdiagnosis of lung cancer with low-dose computed tomography screening: meta-analysis of the randomised clinical trials.
    Brodersen J; Voss T; Martiny F; Siersma V; Barratt A; Heleno B
    Breathe (Sheff); 2020 Mar; 16(1):200013. PubMed ID: 32194774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for Lung Cancer With Low-Dose Computed Tomography: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Jonas DE; Reuland DS; Reddy SM; Nagle M; Clark SD; Weber RP; Enyioha C; Malo TL; Brenner AT; Armstrong C; Coker-Schwimmer M; Middleton JC; Voisin C; Harris RP
    JAMA; 2021 Mar; 325(10):971-987. PubMed ID: 33687468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do we know enough about the effect of low-dose computed tomography screening for lung cancer on survival to act? A systematic review, meta-analysis and network meta-analysis of randomised controlled trials.
    Yang H; Varley-Campbell J; Coelho H; Long L; Robinson S; Snowsill T; Griffin E; Peters J; Hyde C
    Diagn Progn Res; 2019; 3():23. PubMed ID: 31890897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do we know enough about the effect of low-dose computed tomography screening for lung cancer on mortality to act? An updated systematic review, meta-analysis and network meta-analysis of randomised controlled trials 2017 to 2021.
    Duer E; Yang H; Robinson S; Grigore B; Sandercock J; Snowsill T; Griffin E; Peters J; Hyde C
    Diagn Progn Res; 2023 Dec; 7(1):26. PubMed ID: 38072977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overdiagnosis in low-dose computed tomography screening for lung cancer.
    Patz EF; Pinsky P; Gatsonis C; Sicks JD; Kramer BS; Tammemägi MC; Chiles C; Black WC; Aberle DR;
    JAMA Intern Med; 2014 Feb; 174(2):269-74. PubMed ID: 24322569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation.
    Snowsill T; Yang H; Griffin E; Long L; Varley-Campbell J; Coelho H; Robinson S; Hyde C
    Health Technol Assess; 2018 Nov; 22(69):1-276. PubMed ID: 30518460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for prostate cancer.
    Ilic D; Neuberger MM; Djulbegovic M; Dahm P
    Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD004720. PubMed ID: 23440794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung Cancer Screening with Low-Dose CT in Smokers: A Systematic Review and Meta-Analysis.
    Hunger T; Wanka-Pail E; Brix G; Griebel J
    Diagnostics (Basel); 2021 Jun; 11(6):. PubMed ID: 34198856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer-Specific Mortality, All-Cause Mortality, and Overdiagnosis in Lung Cancer Screening Trials: A Meta-Analysis.
    Ebell MH; Bentivegna M; Hulme C
    Ann Fam Med; 2020 Nov; 18(6):545-552. PubMed ID: 33168683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Computed Tomographic Screening Promotion With Lung Cancer Overdiagnosis Among Asian Women.
    Gao W; Wen CP; Wu A; Welch HG
    JAMA Intern Med; 2022 Mar; 182(3):283-290. PubMed ID: 35040922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung cancer screening overdiagnosis: reports of overdiagnosis in screening for lung cancer are grossly exaggerated.
    Mortani Barbosa EJ
    Acad Radiol; 2015 Aug; 22(8):976-82. PubMed ID: 25772581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of postscreening follow-up time and participant characteristics on estimates of overdiagnosis from lung cancer screening trials.
    Li M; Zhang L; Charvat H; Callister ME; Sasieni P; Christodoulou E; Kaaks R; Johansson M; Carvalho AL; Vaccarella S; Robbins HA
    Int J Cancer; 2022 Nov; 151(9):1491-1501. PubMed ID: 35809038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do competing causes of mortality contribute to overdiagnosis in lung cancer screening?
    Durham DD; Croswell JM; Marcus PM
    Lung Cancer; 2021 Mar; 153():21-24. PubMed ID: 33445120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of overdiagnosis in randomised trials of cancer screening: an overview and re-analysis of systematic reviews.
    Voss T; Krag M; Martiny F; Heleno B; Jørgensen KJ; Brandt Brodersen J
    Cancer Epidemiol; 2023 Jun; 84():102352. PubMed ID: 36963292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung Cancer Screening with Low-Dose CT: a Meta-Analysis.
    Hoffman RM; Atallah RP; Struble RD; Badgett RG
    J Gen Intern Med; 2020 Oct; 35(10):3015-3025. PubMed ID: 32583338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung cancer screening with helical computed tomography in older adult smokers: a decision and cost-effectiveness analysis.
    Mahadevia PJ; Fleisher LA; Frick KD; Eng J; Goodman SN; Powe NR
    JAMA; 2003 Jan; 289(3):313-22. PubMed ID: 12525232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for lung cancer with low-dose computed tomography: a systematic review and meta-analysis of the baseline findings of randomized controlled trials.
    Gopal M; Abdullah SE; Grady JJ; Goodwin JS
    J Thorac Oncol; 2010 Aug; 5(8):1233-9. PubMed ID: 20548246
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.